France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook

The veterinary active pharmaceutical ingredients manufacturing market in France is expected to reach a projected revenue of US$ 513.5 million by 2030. A compound annual growth rate of 7.5% is expected of France veterinary active pharmaceutical ingredients manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$309.0
Forecast, 2030 (US$M)
$513.5
CAGR, 2024 - 2030
7.5%
Report Coverage
France

France veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (US$M)

France

Related Markets

France veterinary active pharmaceutical ingredients manufacturing market highlights

  • The France veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 309.0 million in 2023 and is expected to reach USD 513.5 million by 2030.
  • The France market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
  • In terms of segment, in house was the largest revenue generating service type in 2023.
  • Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.


Veterinary active pharmaceutical ingredients manufacturing market data book summary

Market revenue in 2023USD 309.0 million
Market revenue in 2030USD 513.5 million
Growth rate7.5% (CAGR from 2023 to 2030)
Largest segmentIn house
Fastest growing segmentContract Outsourcing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIn House, Contract Outsourcing
Key market players worldwideZoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries


Other key industry trends

  • In terms of revenue, France accounted for 3.6% of the global veterinary active pharmaceutical ingredients manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • France is the fastest growing regional market in Europe and is projected to reach USD 513.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies

Name Profile # Employees HQ Website

France veterinary active pharmaceutical ingredients manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.


In house was the largest segment with a revenue share of 65.24% in 2023. Horizon Databook has segmented the France veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.


The veterinary API manufacturing market is anticipated to exhibit high growth in France over the forecast period. This can be attributed to the growing adoption of pets and the need for increasing livestock production.

Furthermore, France ranks third, after Germany and Russia, to have the highest number of companion animals. Moreover, the availability of abundant scientific & technical expertise and increased R&D & launch of international projects are expected to create growth opportunities in France.

Furthermore, the presence of government institutions that focus on ensuring the safety of veterinary medicinal products, such as the French Agency for Veterinary Medicinal Products (ANMV), is contributing to market growth.

Reasons to subscribe to France veterinary active pharmaceutical ingredients manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France veterinary active pharmaceutical ingredients manufacturing market databook

  • Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into France veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)

France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

France veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more